Town and Country-based Defender Pharmaceuticals inks deal with U.S. Army to develop tropical disease vaccines


Defender Pharmaceuticals said Monday it has entered into an exclusive license agreement with part of the U.S. Army Medical Research and Development Command to develop and commercialize eight vaccines for tropical diseases.

Previous Brigham and Women's nurses petition to remove perioperative VP
Next Houston medtech co. VenoStent completes $16M Series A round